Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
The emergence of Plasmodium falciparum parasites resistant to artemisinins compromises the efficacy of Artemisinin Combination Therapies (ACTs), the global first-line malaria treatment. Artemisinin resistance is a complex genetic trait in which nonsynonymous SNPs in PfK13 cooperate with other geneti...
主要な著者: | Nayak, S, Peto, TJ, Kucharski, M, Tripura, R, Callery, JJ, Quang Huy, DT, Gendrot, M, Lek, D, Nghia, HDT, van der Pluijm, RW, Dong, N, Long, LT, Vongpromek, R, Rekol, H, Hoang Chau, N, Miotto, O, Mukaka, M, Dhorda, M, von Seidlein, L, Imwong, M, Roca, X, Day, NPJ, White, NJ, Dondorp, AM |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Nature Research
2024
|
類似資料
-
Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
著者:: Nayak, Sourav, 等
出版事項: (2025) -
Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
著者:: Sourav Nayak, 等
出版事項: (2024-12-01) -
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
著者:: Peto, TJ, 等
出版事項: (2022) -
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
著者:: van der Pluijm, RW, 等
出版事項: (2022) -
Triple artemisinin-based combination therapies for malaria – a new paradigm?
著者:: van der Pluijm, RW, 等
出版事項: (2020)